Psychiatric Medication, Practically

Does Buspar Have Withdrawal? What Stopping Is Like

Save

Buspirone (Buspar) generally has a much milder discontinuation profile than SSRIs or benzodiazepines, without the well-documented withdrawal syndrome seen in those classes. This article covers the research, the caveat for long-term use, and what symptoms are still worth mentioning to your prescriber before or after you stop.

Last updated: July 2026

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

Does buspirone (Buspar) cause withdrawal like antidepressants do?

Buspirone is generally described as having a notably milder discontinuation profile than SSRIs, SNRIs, or benzodiazepines -- it isn't associated with the same well-documented antidepressant discontinuation syndrome that shows up consistently in serotonin-acting antidepressant research 1. That's one of the reasons it's sometimes chosen specifically for anxiety when a milder overall side-effect and discontinuation profile matters. It doesn't mean stopping is guaranteed to be symptom-free for every person, but it means the population-level pattern reported in the literature is reassuring compared to many other psychiatric medications, including several used for the same anxiety symptoms.

Why would an anti-anxiety medication have a different profile than SSRIs?

Buspirone works differently from both SSRIs and benzodiazepines at the receptor level, and it isn't in either of the two classes most strongly associated with a defined discontinuation or dependence pattern. Broader reviews of psychotropic medication discontinuation describe this kind of class-level variation clearly: some drugs produce a recognizable withdrawal syndrome, and others -- buspirone among them -- generally don't, based on the evidence gathered so far 2. That's a meaningful, evidence-based reason for the reassurance, not just an assumption, and it's part of why prescribers sometimes reach for it specifically when a gentler stopping profile matters to a person's plan.

Is there a caveat for people who've taken it a long time?

The main caveat in the available evidence is that most of what's documented reflects shorter-term use; data on stopping buspirone after years of continuous use is thinner. That doesn't mean long-term use makes stopping dangerous -- there's no strong signal pointing that direction -- but it does mean "we don't have much data" is a more honest answer than "definitely nothing happens," especially if you've been on it for an extended stretch. That distinction is worth naming to your prescriber directly, rather than assuming your years of use are automatically covered by research on shorter courses.

What symptoms, if any, should you watch for?

Because buspirone's profile is milder, most people don't need an extensive symptom watch-list the way they might with an SSRI or SNRI. Still, any new anxiety, irritability, or physical discomfort that shows up after stopping is worth mentioning rather than assuming it's unrelated, since your prescriber can help sort out whether it traces back to the medication change, a return of your original anxiety, or something else entirely. General medication references describe buspirone's mechanism as distinct from both SSRIs and benzodiazepines 3, which is consistent with why its stopping experience tends to look different too.

When it's still worth a conversation before stopping

Buspar's comparatively gentle discontinuation profile is genuinely reassuring, but "generally mild" still means talking with your prescriber before stopping, especially after long-term use where the evidence is thinner. Who's more likely to get withdrawal from psychiatric medications in general offers useful context, and if you're also taking another psychiatric medication, why SNRIs are harder to stop than SSRIs shows how much this varies drug to drug -- worth knowing before assuming any one medication behaves like another, buspirone included, since two medications can look similar on paper while behaving very differently once you actually stop taking them.

Common questions

Buspirone isn't considered to carry the dependence risk associated with benzodiazepines, which is part of why its discontinuation profile also tends to be milder -- though your prescriber is the best source for how that applies to your specific situation.

Whether to taper or stop more directly is still a decision to make with your prescriber based on your dose and duration of use, even though the general research suggests a milder discontinuation experience than many other psychiatric medications.

That could reflect your original anxiety resurfacing rather than a withdrawal effect specifically, since buspirone's discontinuation profile doesn't typically produce new physical symptoms the way SSRI withdrawal can -- worth discussing with your prescriber to sort out which it is.

The evidence specific to long-term use is thinner than for shorter courses, so it's a fair question to raise directly with your prescriber rather than assume it behaves identically.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

If things feel heavy, a person is available anytime — call or text 988.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

If anything feels off after stopping Buspar

  • —New or worsening anxiety that feels different from before
  • —Any symptom that feels severe rather than mild
  • —Confusion or symptoms that don't match your expectations
  • —Thoughts of self-harm or suicide

Buspirone's discontinuation profile is generally mild in the research, but individual experiences vary and long-term-use data is limited. This is general information, not medical advice. If you are in crisis, call or text 988 (Suicide & Crisis Lifeline), free and available 24/7.

References

  1. 1.Fava GA, Gatti A, Belaise C, Guidi J, Offidani E (2015). Withdrawal Symptoms after Selective Serotonin Reuptake Inhibitor Discontinuation: A Systematic Review. Psychotherapy and Psychosomatics. doi:10.1159/000370338 ✓antidepressant-discontinuationssri-withdrawaldiscontinuation-syndrome
  2. 2.Cosci F, Chouinard G (2020). Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications. Psychotherapy and Psychosomatics. doi:10.1159/000506868 ✓withdrawal-syndromepsychotropic-discontinuationprotracted-withdrawal
  3. 3.National Institute of Mental Health (NIMH) (2024). Mental Health Medications. National Institute of Mental Health (NIMH). link ✓ssri-anti-anxiety-medsptsd-medicationdepression-treatmentdrinking-on-antidepressants

3 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — every citation independently verified. Editorial policy

← Back to the health library